1. Home
  2. ALT vs DFP Comparison

ALT vs DFP Comparison

Compare ALT & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • DFP
  • Stock Information
  • Founded
  • ALT 1997
  • DFP 2013
  • Country
  • ALT United States
  • DFP United States
  • Employees
  • ALT N/A
  • DFP N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • DFP Investment Managers
  • Sector
  • ALT Health Care
  • DFP Finance
  • Exchange
  • ALT Nasdaq
  • DFP Nasdaq
  • Market Cap
  • ALT 472.3M
  • DFP 420.8M
  • IPO Year
  • ALT N/A
  • DFP N/A
  • Fundamental
  • Price
  • ALT $5.32
  • DFP $20.29
  • Analyst Decision
  • ALT Strong Buy
  • DFP
  • Analyst Count
  • ALT 8
  • DFP 0
  • Target Price
  • ALT $21.00
  • DFP N/A
  • AVG Volume (30 Days)
  • ALT 3.0M
  • DFP 56.2K
  • Earning Date
  • ALT 05-08-2025
  • DFP 01-01-0001
  • Dividend Yield
  • ALT N/A
  • DFP 6.73%
  • EPS Growth
  • ALT N/A
  • DFP N/A
  • EPS
  • ALT N/A
  • DFP N/A
  • Revenue
  • ALT $20,000.00
  • DFP N/A
  • Revenue This Year
  • ALT N/A
  • DFP N/A
  • Revenue Next Year
  • ALT N/A
  • DFP N/A
  • P/E Ratio
  • ALT N/A
  • DFP N/A
  • Revenue Growth
  • ALT N/A
  • DFP N/A
  • 52 Week Low
  • ALT $5.14
  • DFP $15.45
  • 52 Week High
  • ALT $11.16
  • DFP $19.31
  • Technical
  • Relative Strength Index (RSI)
  • ALT 39.42
  • DFP 43.73
  • Support Level
  • ALT $5.60
  • DFP $20.26
  • Resistance Level
  • ALT $6.16
  • DFP $20.59
  • Average True Range (ATR)
  • ALT 0.35
  • DFP 0.18
  • MACD
  • ALT 0.01
  • DFP -0.02
  • Stochastic Oscillator
  • ALT 17.65
  • DFP 18.92

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.

Share on Social Networks: